Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Gessner
Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study
Thorax
Pulmonary
Respiratory Medicine
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Related publications
A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD
Thorax
Pulmonary
Respiratory Medicine
Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma
Pulmonary Pharmacology and Therapeutics
Biochemistry
Medicine
Pulmonary
Respiratory Medicine
Pharmacology
Comparison of Once Daily Versus Twice Daily Olmesartan in Patients With Chronic Kidney Disease
International Journal of Nephrology and Renovascular Disease
Nephrology
Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma
Respiratory Research
Pulmonary
Respiratory Medicine
Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial
Journal of Asthma and Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Trough to Peak Ratio of Once-Daily Lisinopril and Twice-Daily Captopril in Patients With Essential Hypertension
Journal of Human Hypertension
Internal Medicine
P250 Effects of 12 Weeks of Once-Daily Tiotropium and Olodaterol Fixed-Dose Combination on Exercise Endurance in Patients With Copd
Thorax
Pulmonary
Respiratory Medicine
Once-Daily Netarsudil vs Twice-Daily Timolol in Patients With Elevated Intraocular Pressure, the Randomized Phase 3 ROCKET-4 Study
American Journal of Ophthalmology
Ophthalmology
